SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
344.20    8.00 (2.38%)
Bid:
344.00
Ask:
344.40
Spread: 0.40 (0.116%)
Market Cap: £2.51b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Trading Statement

14 May 2025 07:00

RNS Number : 5363I
TP ICAP Group plc
14 May 2025
 

TP ICAP GROUP PLC (the "Group")

 

14 May 2025

 

Trading Update for the three months ended 31 March 2025

 

Note: comparisons are to Q1 2024 unless otherwise indicated; all percentage movements are in constant currency[1].

Total revenue grew 10% to £629m, the best quarter ever registered by the Group, benefiting from a period of heightened market volatility which was driven by the uncertainty of U.S. trade policies.

Global Broking revenue increased 14%, with the division performing strongly across all asset classes, capitalising on the exceptionally favourable market conditions.

Liquidnet delivered another strong quarter, with revenue up 16%.

Energy & Commodities (E&C) revenue was unchanged, in line with our expectations, reflecting a competitive hiring market for brokers in 2024.

Following a record performance in Q1 2024, including one-off revenue, Parameta Solutions revenue increased by 6% in Q1 2025.

Outlook

The Board remains comfortable with current market expectations for 2025 adjusted EBIT, following a strong first quarter performance and despite the recent weakening of the U.S. Dollar[2].

Approximately 60% of Group revenues and 40% of Group costs are USD-denominated.

Business update

 

At our full year 2024 results, announced on 11 March 2025, the Group stated that should it proceed with a potential minority listing of Parameta Solutions, this could occur as early as Q2 2025.

Following the recent market turbulence, the Board will now keep under review the appropriate timing for any potential minority listing.

2025 Annual General Meeting

The Group will host its Annual General Meeting today, Wednesday 14 May 2025, at 2.15pm (BST) at the offices of Allen & Overy Shearman Sterling LLP, One Bishops Square, London, E1 6AD.

2025 half year results

The Group will report its results for the six months ended 30 June 2025 on 6 August 2025.

 

Forward looking statements

This document contains forward looking statements with respect to the financial condition, results and business of the Company. By their nature, forward looking statements involve risk and uncertainty and there may be subsequent variations to estimates. The Company's actual future results may differ materially from the results expressed or implied in these forward-looking statements.

 

Enquiries

Group Company Secretary Vicky Hart

Email: companysecretarial@tpicap.com

 

Analysts and investors Dominic Lagan Direct: +44 (0) 20 3933 0447

Email: dominic.lagan@tpicap.com  

Media Richard Newman Direct: +44 (0) 7469 039 307

Email: richard.newman@tpicap.com

  

About TP ICAP

· TP ICAP connects buyers and sellers in global financial, energy and commodities markets.

· It is the world's leading wholesale market intermediary, with a portfolio of businesses that provide broking services, data & analytics and market intelligence, trusted by clients around the world.

· We operate from more than 60 offices across 28 countries, supporting brokers with award-winning and market-leading technology.

 

Further information on the company and its activities is available on the Company's website:

www.tpicap.com.

 


[1] Note the average GBP/ U.S. Dollar exchange rate was $1.26 in Q1 2024 and Q1 2025. Consequently, movements on a constant currency basis and on a reported basis are the same.

 

[2] On 30th April the Sterling to U.S. Dollar rate was $1.34, compared with an average of $1.28 for full year 2024.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFVAETIVLIE
Date   Source Headline
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20254:45 pmRNSHolding(s) in Company
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20254:30 pmRNSHolding(s) in Company
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20257:05 amRNSLaunch of fourth share buyback programme of £30m
11th Mar 20257:00 amRNSFinal Results
6th Mar 20254:35 pmRNSHolding(s) in Company
13th Feb 20258:00 amRNSHolding(s) in Company
10th Feb 20254:30 pmRNSHolding(s) in Company
23rd Jan 20255:30 pmRNSDirectorate Change
17th Jan 20252:45 pmRNSHolding(s) in Company
17th Jan 20257:00 amRNSTransaction in Own Shares
16th Jan 20257:00 amRNSTransaction in Own Shares
15th Jan 20257:00 amRNSTransaction in Own Shares
14th Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20257:00 amRNSTransaction in Own Shares
10th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
7th Jan 20257:00 amRNSTransaction in Own Shares
6th Jan 20257:00 amRNSTransaction in Own Shares
3rd Jan 20257:00 amRNSTransaction in Own Shares
2nd Jan 20257:00 amRNSTransaction in Own Shares
31st Dec 20247:00 amRNSTransaction in Own Shares
30th Dec 20247:00 amRNSTransaction in Own Shares
27th Dec 20247:00 amRNSTransaction in Own Shares
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 202410:21 amRNSHolding(s) in Company
20th Dec 20247:00 amRNSTransaction in Own Shares
14th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 20244:15 pmRNSHolding(s) in Company
13th Nov 20243:00 pmRNSDirector/PDMR Shareholding
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTransaction in Own Shares
11th Nov 20247:00 amRNSTransaction in Own Shares
6th Nov 20247:00 amRNSTransaction in Own Shares
5th Nov 20247:05 amRNSTransaction in Own Shares
5th Nov 20247:00 amRNSTrading Statement
4th Nov 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.